Form 8275-R for Cannabis Returns: Disclosure, Not a Shield

Form 8275-R is the most misunderstood form in cannabis tax. Operators hear "disclose it" and assume the form is a shield that makes a shaky position safe. It is not. It is a disclosure — and the point of disclosing a cannabis return position is to make a defensible one supported rather than unnecessarily exposed, never to rescue one that was wrong to begin with.

Jamie Williams, EA
Form 8275-R for Cannabis Returns: Disclosure, Not a Shield

This one is for the boutique cultivator who is taking a position that is defensible but not routine — a §471(c) simplified inventory method, a first corrected medical-versus-adult-use allocation, maybe an amended-return position resting on a §471-11 correction — and who has been told, by someone, to "disclose it." The advice is not wrong. But most operators have no idea what Form 8275-R does, what it does not do, or whether filing it actually protects them. So before you attach a form to a return in the belief that it makes the position bulletproof, here is what disclosure is really for.

What Form 8275 and 8275-R actually are (and are not)

There are two disclosure forms, and the difference between them is narrow but real.

Form 8275, the Disclosure Statement, is used to disclose a return position that is not otherwise adequately disclosed on the return itself. Its purpose is to establish "adequate disclosure" and, in doing so, reduce exposure to the §6662 accuracy-related penalty. The position still has to be substantively defensible — 8275 is about making sure the IRS can see what you did, not about making what you did correct.

Form 8275-R, the Regulation Disclosure Statement, is the narrower cousin. It is used specifically for a position that is contrary to a Treasury regulation. It names the regulation you are taking a position against. That is the whole distinction that governs which form you use: if your position departs from a Treasury regulation, it is an 8275-R situation; if it is simply a non-routine position not adequately disclosed elsewhere, it is an 8275 situation.

Here is the part operators miss. Both forms are disclosure vehicles. Neither is substantive authority. Disclosure can reduce your penalty exposure. It does nothing to reduce your tax exposure. The IRS can accept that you disclosed the position clearly, agree you owe no accuracy penalty, and still disallow the position outright and assess the tax plus interest. Filing the form does not move the odds that your position is right — it moves the odds that, if you turn out to be wrong, you are not also penalized for having hidden it.

And not every non-routine position needs disclosure at all. Plenty of properly supported positions need none. Whether the answer is 8275, 8275-R, or nothing is a position-specific call, made with your representative — not a reflex.

When disclosure may make sense for a cannabis return

A few situations where disclosure earns its place on a cannabis return:

When disclosure does not save you

Just as important is knowing what disclosure cannot do.

Disclosure does not rescue a position with no substantive authority. If someone is filing a refund claim on the theory that "medical cannabis was always Schedule III," there is no basis for it — the rescheduling took effect in 2026, it is not retroactive, and the IRS is actively pushing back on cannabis refund claims. Disclosing a position with no support does not make it supported; a frivolous position disclosed is still frivolous.

Disclosure does not cover a tax-avoidance or "listed" transaction. Those carry their own stricter regime, and 8275 and 8275-R are not the tools for them.

And disclosure does not cure a factual misstatement. If revenue is understated, no form fixes that — disclosure is for positions, not for false statements. You cannot disclose your way out of wrong numbers.

How this fits the return I sign

When I sign a return as your Enrolled Agent, I am signing it under my Circular 230 obligations, with a written §471(c) and COGS position behind it. Form 8275-R, where it is warranted, is the disclosure companion to that position — the document that records the position was taken transparently, against the specific regulation, in the open.

The deliverable I am after is a return position that is both supported and disclosed: supported by workpapers that build COGS from your actual records, and disclosed on the right form where the position calls for it. I cover that support side in the full-absorption workpapers guide in this library, and the underlying method question in the §471(c) guide. That combination — a substantively defensible position, taken in the open — is the one the IRS respects most. Disclosure without support is just an announcement that you took a weak position. Support without disclosure can leave a non-routine position needlessly exposed to penalty. The point is to have both, or to make an informed decision that neither is needed. (The corrected allocation this so often protects is the one I break down in The Medical-vs-Adult-Use Allocation.)

Getting it right: a short checklist

  1. Decide first whether the position is routine — in which case it likely needs no disclosure at all — or non-routine, in which case disclosure is on the table.
  2. Confirm the position has substantive authority before you disclose it. Disclosure is not a substitute for being right; it is protection for a position that is already defensible.
  3. Determine which vehicle fits: Form 8275 for a non-routine position not adequately disclosed elsewhere, Form 8275-R for a position contrary to a Treasury regulation, or no disclosure where the position is routine and supported — and substantively back it up either way.
  4. Keep the supporting §471 inventory-method memo and the allocation workpapers in the return file, alongside the disclosure, so the position and its backup live together.

The two-sided risk

The danger here cuts both ways. Fail to disclose a non-routine position and you leave yourself open to accuracy penalties you could have avoided. Disclose a weak position as though it were strong and you have effectively raised your hand and invited the IRS to test it — without having made it any more correct. Both failure modes have the same cure: a position that is substantively defensible, paired with the right disclosure decision — which sometimes means filing 8275-R, sometimes 8275, and sometimes, deliberately, nothing at all. That call is exactly the kind of judgment the $375 audit is built to make.

Start with the $375 allocation audit and a ten-minute fit call. I'll evaluate your return position, tell you straight whether it needs disclosure — and if so, which form — and, if you engage me for return signing, prepare the §471 method memo and the appropriate disclosure so the position is supported, not exposed. If it needs no disclosure at all, that is a good answer too, and you'll have it in ten minutes.

Book the $375 audit
Next in the library Full-Absorption Workpapers for Boutique Cultivators Read the guide →

Don't miss the next issue

This article is educational and does not constitute tax or legal advice. No client relationship is created by reading it. Federal cannabis scheduling and IRS guidance are changing rapidly in 2026; verify the current status before acting. For positions specific to your operation, engage under a signed representation agreement (Form 2848).

Talk to a licensed EA

See what §280E is really costing you.

Book a 30-minute consult with an Enrolled Agent — no obligation.